|
|
|
Insider
Information: |
Paul Steven M |
Relationship: |
|
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
1,185,025 |
|
Indirect Shares
|
632,151 |
|
|
Direct
Value |
$39,384,943 |
|
|
Indirect Value
|
$32,026,074 |
|
|
Total
Shares |
1,817,176 |
|
|
Total
Value |
$71,411,017 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
EVP, Science and Techn... |
2010-02-01 |
38,897 |
2010-02-01 |
39,040 |
Premium* |
|
Sigma-Aldrich Corp |
SIAL |
Director |
2015-11-18 |
0 |
2007-01-02 |
0 |
Premium* |
|
Sage Therapeutics, Inc. |
SAGE |
|
2019-03-21 |
272,777 |
2022-11-28 |
593,111 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2022-04-01 |
1,000 |
2015-01-26 |
0 |
Premium* |
|
Voyager Therapeutics, Inc. |
VYGR |
President and CEO, Dir... |
2016-01-14 |
872,351 |
|
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2024-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
officerTitle |
|
2006-02-02 |
4 |
S |
$57.00 |
$353,457 |
D/D |
(6,201) |
89,656 |
|
- |
|
LLY |
Eli Lilly & Co |
officerTitle |
|
2006-01-20 |
4 |
A |
$57.04 |
$1,230,011 |
D/D |
21,564 |
98,656 |
|
- |
|
LLY |
Eli Lilly & Co |
EVP, Science and Technology |
|
2007-06-01 |
4 |
D |
$58.62 |
$71,868 |
D/D |
(1,226) |
43,479 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, Science and Technology |
|
2007-05-15 |
4 |
D |
$59.60 |
$113,240 |
D/D |
(1,900) |
40,132 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, Science and Technology |
|
2007-05-21 |
4 |
D |
$59.60 |
$5,568,726 |
D/D |
(93,435) |
44,705 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, Science and Technology |
|
2004-09-27 |
4 |
D |
$63.66 |
$533,853 |
D/D |
(8,386) |
30,818 |
|
- |
|
LLY |
Eli Lilly & Co |
EVP, Science and Technology |
|
2003-08-05 |
4 |
S |
$64.87 |
$648,716 |
I/I |
(10,000) |
28,877 |
|
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2015-08-03 |
4 |
AS |
$66.42 |
$1,341,692 |
D/D |
(20,000) |
703,650 |
0 |
- |
|
SIAL |
Sigma-Aldrich Corp |
Director |
|
2011-01-03 |
4 |
A |
$67.30 |
$80,760 |
D/D |
1,200 |
6,000 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2015-07-01 |
4 |
AS |
$67.46 |
$1,388,028 |
D/D |
(20,000) |
723,650 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2015-06-01 |
4 |
AS |
$71.36 |
$1,446,799 |
D/D |
(20,000) |
743,650 |
0 |
- |
|
LLY |
Eli Lilly & Co |
EVP, Science and Technology |
|
2004-06-02 |
5 |
D |
$74.74 |
$46,115 |
D/D |
(617) |
18,314 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2015-01-26 |
4 |
B |
$95.00 |
$95,000 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
PRESIDENT & CEO |
|
2021-08-17 |
4 |
B |
$105.63 |
$124,960 |
I/I |
1,183 |
107,668 |
0.01 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
PRESIDENT & CEO |
|
2021-08-18 |
4 |
B |
$106.10 |
$125,304 |
I/I |
1,181 |
108,849 |
0.01 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2020-02-10 |
4 |
AS |
$130.00 |
$3,900,000 |
D/D |
(30,000) |
1,000 |
0 |
% |
|
SIAL |
Sigma-Aldrich Corp |
Director |
|
2015-11-18 |
4 |
D |
$140.00 |
$66,920 |
D/D |
(478) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2020-12-18 |
4 |
AS |
$140.00 |
$2,100,000 |
D/D |
(15,000) |
1,000 |
0 |
% |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-02-25 |
4 |
AS |
$161.00 |
$322,000 |
I/I |
(2,000) |
70,900 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-01 |
4 |
AS |
$161.00 |
$418,600 |
I/I |
(2,600) |
190,700 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-18 |
4 |
AS |
$161.01 |
$607,977 |
I/I |
(3,775) |
186,925 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-02-15 |
4 |
AS |
$161.02 |
$7,964,210 |
I/I |
(49,461) |
74,443 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-21 |
4 |
AS |
$161.02 |
$1,268,824 |
I/I |
(7,879) |
122,400 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-03-20 |
4 |
AS |
$161.20 |
$9,136,582 |
I/I |
(56,646) |
130,279 |
0 |
- |
|
SAGE |
Sage Therapeutics, Inc. |
|
|
2019-02-19 |
4 |
AS |
$161.37 |
$249,373 |
I/I |
(1,543) |
72,900 |
0 |
- |
|
131 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|